trog cancer research has been successful in being awarded a $1.5 million grant (2018-2020) under the cancer australia support for cancer clinical trials program. the funding from cancer australia provides essential infrastructure for trog to build our capacity to undertake cancer...

the board of trog cancer research is pleased to announce the appointment of susan goode as the new trog chief executive officer. susan is formerly the centre manager for the hunter cancer research alliance at the university of newcastle. in this role, she was key player in a strate...

the inaugural trog trek has raised more than $10,000 for trog's cancer clinical trials. the group of volunteers took on a five-day 50 kilometre trek in the spectacular bay of fires region in north east tasmania in march. each of the team members either held fundraising events or...

p style="font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2; text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-style: initial; text-decoration-color: initial;word-spacing:0px">span style="font-size:11.0pt; font-family:">trog board presid...

more than 270 people attended the trog 2018 annual scientific meeting (asm) in hobart, tasmania from 19-22 march. the asm was the 30th for trog and attendees included oncologists, radiation therapists, physicists, study coordinators and data managers. delegates heard from a host of...

trog stalwart professor bryan burmeister is retiring from his position at princess alexandra hospital (pah) in brisbane. the highly respected radiation oncologist has worked in various positions with queensland health for 29 years. he has been at pah for the past 16 years. profe...

with every millimetre counting in radiation therapy treatment, a new world first study developed in australia could eventually benefit cancer patients across the world. a new trog study called 'liver ablative radiotherapy with kim' or td 17.03 lark has received $583,000 from the ca...

a new study investigating the use of cutting-edge stereotactic ablative _ radiotherapy (sabr) to treat patients with inoperable kidney cancer has been received $589,000 in funding from cancer australia. trog researcher, a/prof shankar siva, from the university of melbourne and the ...

figure>img alt="file 20180117 53310 9zjg6j.jpg?ixlib=rb 1.1" src="https://images.theconversation.com/files/202371/original/file-20180117-53310-9zjg6j.jpg?ixlib=rb-1.1.0&q=45&auto=format&w=754&fit=clip" /> figcaption>a liquid biopsy is far less invasive than a standard biopsy, where a...

fabulous food was the highlight of the recent trog trek fundraising dinner, with apprentice chefs from the kurri kurri tafe cooking up a feast of culinary delights. the students put all their learnings to the test to come up with a spectacular three course gourmet meal. the even...

a new international trial, which will examine whether the addition of a new type of targeted radiation treatment is more effective for patients with advanced lung, breast or prostate cancer, is now up and running in australia. trog cancer research will lead the trial in australia c...

trog cancer research is pleased to announce the appointment of john cleary to its board. ceo joan torony said that john was a perfect fit for trog’s board as he has more than 20 years’ experience at a senior management and executive level in both the not-for-profit and for-profit indu...

more than 65 people showed their support for cancer research by attending a high tea fundraising event hosted by trog cancer research. the event was held in newcastle, where the trog cancer research has its headquarters. on top of a delicious high tea, guests also took part in a silen...